期刊文献+

人脐血CD34^+细胞在NOD/SCID小鼠上有效重建造血系统 被引量:3

Transplanting human umbilical cord blood CD34^+ cells reconstitutes hematopoietic system in NOD/SCID mice
原文传递
导出
摘要 目的探讨人脐血CD34+造血干细胞在非肥胖糖尿病/重症联合免疫缺陷(no obese diabetic/severecombined Immunodeficiency,NOD/SCID)小鼠模型上造血重建的作用。方法利用密度梯度离心法,从新鲜脐血中分离出单个核细胞,利用免疫磁珠分选法筛选CD34+造血干细胞,经尾静脉输注入经亚致死剂量照射后的NOD/SCID小鼠体内,移植后3、7、10、14 d分别用断尾法取小鼠外周血,血常规计数外周血动态变化情况;移植后4、6、8、10周,取其外周血,运用PCR法检测外周血中人特异性Alu基因的表达情况。结果免疫磁珠分选得到的CD34+细胞浓度达91.2%,照射后小鼠骨髓腔内有核细胞和巨细胞数量明显减少或消失,达到清髓目的。移植后第3天移植组小鼠外周血各系细胞均明显低于正常组(P<0.01),移植后第7天,移植组小鼠外周血象开始恢复,明显高于阴性对照组[白细胞:(3.90±0.53)×109/L vs(1.30±0.18)×109/L,血红蛋:(139.8±5.0)g/L vs(79.8±11.0)g/L,白血小板:(253.0±17.5)×109/L vs(52.0±6.9)×109/L,(P<0.01)],移植后第10天,移植组小鼠外周血象恢复到辐照前水平,与正常组无差别。移植4周后,PCR方法在小鼠外周血中可检测到人特异Alu基因序列,未移植组小鼠照射后2周内全部死亡。结论经照射后的NOD/SCID小鼠通过人脐血CD34+细胞植入可建立起人鼠嵌合模型。NOD/SCID小鼠经照射后,不破坏骨髓造血微环境及造血基质,可用于异基因细胞移植模型。人脐血CD34+细胞移植入NOD/SCID小鼠,其造血系统能有效重建。 Objective To investigate the hematopoietic reconstitution by human umbilical cord blood CD34+ cells in no obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Methods Mono- nuclear cells (MNCs) were isolated from human fresh cord blood by gradient centrifugation, and then CD34 + hematopoietic stem cells were selected by magnetic activated cell sorting. The selected cells were injected into the tail of the NOD/SCID mice after irradiation of sublethal doses. After the sample of peripheral blood were collected by cutting mouse tail at 3, 7, 10, and 14 d after transplantation, dynamic monitoring was performed on the mouse blood . The mice alive were sacrificed and the blood samples were harvested at 4, 6, 8 and 10 weeks after transplantation. The mRNA expression of human-specific gene Alu in the peripheral blood cells were analyzed by PCR. Results The yield proportion of CD34 + cells accounted for 91.2%. Irradiation of sublethal doses obviously reduced the number of karyocytes and giant ceils and even demolished the cells in medullary space. At the third day after transplantation, the peripheral blood cells in each department were significantly lower than those in the normal group (P 〈0.01 ). From the seventh day after transplantation, peripheral blood in transplantation mice began to recover, significantly higher than negative control group [ white cells: (3.90 ± 0. 53) 109/L vs ( 1.30 ±0. 18) 109/L, hemoglobin : ( 139.8 ± 5. 0) g/L vs (79.8 ± 11.0) g/L, platelets : (253.0 ±17.5) 109/L vs (52.0 ± 6.9) 109/L,P 〈 0.01 ]. At 10 d after transplantation, peripheral blood of transplanted mice was back to the level before irradiation, with no significant difference with that of the normal group (P 〉 0. 05 ). In 4 weeks after cell transplantation, there were more and more human-derived hematopoi-etic cells, human specific Alu gene was detected in the peripheral blood in mice. All mice died who received no transplantion in 2 weeks after irradiation. Conclusion Human-mouse chimeric immune model is built in irradiated NOD/SCID mice transplanted by cord blood CD34+ cells. Irradiation can not destroy the bone marrow microenvironment and hemopoietic stromal in NOD/SCID mice, and the mice can be used for allogeneic cell transplantation model. The hematopoietic system, humoral immunity is effective reconstructed in NOD/SCID mice after human umbilical cord blood CD34 + cells transplantion.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第11期1136-1140,共5页 Journal of Third Military Medical University
基金 贵州省科技厅(黔科合计2008-1003) 遵义市"15851"人才工程项目(市15851人才办2008-9) 贵州省教育厅培育项目(黔科教2009-113)~~
关键词 人脐血 NOD/SCID小鼠 CD34+干细胞 造血重建 human umbilical cord blood no obese diabetic/severe combined immunodeficiencymice CD34 + stem cells hematopoietic reconstitution
  • 相关文献

参考文献19

  • 1Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse[J]. Nature, 1983, 301(5900) : 527 - 530.
  • 2Chang N H, Inman R D, Dick J E, et al. Bone marrow-derived human hematopoietic stem ceils engraft NOD/SCID mice and traffic appropri ately to an inflammatory stimulus in the joint [ J ]. J Rheumatol, 2010, 37 (3) : 496 - 502.
  • 3Salles I I, Thijs T, Brunaud C, et al. Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34 ^6 cells are functionally active in an ex vivo flow model of thrombosis [ J ]. Blood, 2009, 114(24) : 5044 -5051.
  • 4向茜茜,孔佩艳,赵艳,曾东风,刘红,陈幸华,张曦,李杰平,彭贤贵,高蕾,高力.造血干细胞移植治疗儿童血液肿瘤及难治性血液病53例临床观察[J].第三军医大学学报,2010,32(20):2228-2231. 被引量:5
  • 5万鼎铭,索金艳,孙慧,孙玲,谢新生,王桂菊,姜中兴,袁小庚,成琳.同胞相合移植单个核细胞和CD34+细胞输入数量与造血重建的关系[J].郑州大学学报(医学版),2010,45(4):654-655. 被引量:4
  • 6Nauta A J, Kruisselbrink A B, Lurvink E, et al. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit[ J]. Exp Hematol, 2005, 33(10): 1249-1256.
  • 7田红霞,林晨,陈少华,杨力建,江振友,高珂,郜世隽,李扬秋.甲氰咪呱对K562细胞诱导脐血T细胞TCR Vβ亚家族克隆性的影响[J].第三军医大学学报,2009,31(17):1637-1640. 被引量:3
  • 8Andre M C, Erbacher A, Gille C, et al. Long-term human CD34^+ stem cell-engrafted nonobese diabetic/SCID/IL-2Rgamma(null) mice show impaired CD8 ^+T cell maintenance and a functional arrest of im- mature NK cells[J]. J Immunol, 2010, 185(5) : 2710 -2720.
  • 9van-Hensbergen Y, Schipper L F, Brand A, et al. Ex vivo culture of human CD34 ^+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model[ J ]. Exp Hematol, 2006, 34 (7) : 943 - 950.
  • 10莫文健,毛平,何秋山,应逸,朱志刚,许艳丽,杜庆华.无血清脐血巨核系祖细胞体外扩增的研究[J].中国实验血液学杂志,2004,12(2):133-137. 被引量:13

二级参考文献56

  • 1刘旭辉,裴仁治,岑东,马俊霞,杜小红,方亚晖.自体外周血干细胞移植物中单个核细胞计数与CD_(34)^+细胞的相关性[J].现代实用医学,2004,16(12):701-703. 被引量:3
  • 2李明,汪明春,张琼丽,杜新.组胺H_2受体阻滞剂阻断再生障碍性贫血患者CD_8^+细胞抑制正常CFU-Mk生长的作用[J].中国病理生理杂志,2005,21(5):936-938. 被引量:1
  • 3Kubota T, Fujiwara H, Ueda Y, et al. Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients [J]. Br J Cancer, 2002, 86(8): 1257 -1261.
  • 4Wang J, Su B, Ding Z, et al . Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells [ J ]. Biochem Biophys Res Commun, 2008, 372 (3) : 491 -496.
  • 5Asakage M, Tsuno N H, Kitayama J, et al . The effect of cimetidine mainly increases CD4^+ cells of peripheral blood T lymphocytes [ J]. Gan To Kagaku Ryoho, 2005, 32( 11 ) : 1576 - 1577.
  • 6Gantner F, Sakai K, Tusche M W,et al . Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8( + ) T cells[J].J Pharmacol Exp Ther, 2002, 303(1) : 300- 307.
  • 7Assaf C, Hummel M, Dippel E, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing[J]. Blood, 2000, 96(2): 640 - 646.
  • 8Jiang Y Z, Mavroudis D A,Dermime S,et al. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells : implications for separating graft-versus-leukemia effect from graft-versus-host disease[ J] . Bone Marrow Transplant, 1997, 19 (9) : 899 - 903.
  • 9Elenkov I J, Webster E, Papanicolaoa D A, et al. Histamine potently suppresses human IL-2 and stimulates IL-10 production via H2 receptors[ J]. The Journal of Immunology, 1988, 161 (5) : 2586 -2593.
  • 10To LB,Haylock DN,Simmons PJ,et al. The biology and clinical uses of blood stem ceils[J]. Biood,1997,89(7) :2 233.

共引文献25

同被引文献54

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部